Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

15.9%

74 terminated/withdrawn out of 466 trials

Success Rate

81.9%

-4.6% vs industry average

Late-Stage Pipeline

21%

97 trials in Phase 3/4

Results Transparency

68%

228 of 334 completed trials have results

Key Signals

13 recruiting228 with results53 terminated21 withdrawn

Enrollment Performance

Analytics

N/A
155(34.9%)
Phase 2
124(27.9%)
Phase 4
78(17.6%)
Phase 1
64(14.4%)
Phase 3
19(4.3%)
Early Phase 1
4(0.9%)
444Total
N/A(155)
Phase 2(124)
Phase 4(78)
Phase 1(64)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (466)

Showing 20 of 466 trials
NCT05748158Not ApplicableRecruiting

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

Role: collaborator

NCT04958798Not ApplicableCompleted

Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities

Role: lead

NCT05987007Not ApplicableNot Yet Recruiting

Sleep Interventions and Neurocognitive Outcomes

Role: lead

NCT04873401Not ApplicableCompleted

Leveraging Social Networks to Increase COVID-19 Testing Uptake

Role: lead

NCT04810624Not ApplicableRecruiting

Relapse Prevention and Changing Habits in Anorexia Nervosa

Role: lead

NCT04663724Not ApplicableRecruiting

Computer - Based Treatment for Social Anxiety Disorder

Role: lead

NCT05412901Not ApplicableSuspended

Scaffolding of Brain Operations

Role: lead

NCT04640636Phase 4Suspended

IM Ketamine vs Midazolam for Suicidal ER Patients

Role: lead

NCT05070793Not ApplicableSuspended

Improving Alcohol Use Disorder Treatment for Gender Minority Populations

Role: lead

NCT07124780Not ApplicableRecruiting

Helping Adults With Obsessive-Compulsive Disorder Succeed at Work

Role: lead

NCT05011266Phase 2Recruiting

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Role: lead

NCT03363256Not ApplicableCompleted

Web-based Addiction Treatment: Cultural Adaptation With American Indians

Role: lead

NCT07594730Not ApplicableNot Yet Recruiting

RCT of Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems

Role: lead

NCT00739765Not ApplicableCompleted

Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder

Role: lead

NCT02645929Completed

Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)

Role: lead

NCT05208190Phase 4Recruiting

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Role: lead

NCT05046353Phase 1Suspended

D-serine AudRem: R33 Phase

Role: lead

NCT06593470Not ApplicableNot Yet Recruiting

Mindfulness-Based Substance Use Prevention (MINDS-UP)

Role: lead

NCT05477901Not ApplicableRecruiting

Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

Role: lead

NCT04458545Phase 1Recruiting

Clinical Trials of Multivalent Opioid Vaccine Components

Role: lead